Luisa Marcon

1.9k total citations
24 papers, 1.7k citations indexed

About

Luisa Marcon is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Luisa Marcon has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 15 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Luisa Marcon's work include HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (13 papers) and HIV/AIDS drug development and treatment (8 papers). Luisa Marcon is often cited by papers focused on HIV Research and Treatment (15 papers), Immune Cell Function and Interaction (13 papers) and HIV/AIDS drug development and treatment (8 papers). Luisa Marcon collaborates with scholars based in United States, Italy and Spain. Luisa Marcon's co-authors include Joseph Sodroski, Norma P. Gerard, Hyeryun Choe, Michael Farzan, Kathleen A. Martin, Craig Gérard, Ying Sun, David L. Nelson, Gunilla B. Karlsson and Naoko Hattori and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Luisa Marcon

23 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luisa Marcon United States 18 955 951 528 303 264 24 1.7k
Gregory F. Burton United States 27 1.7k 1.8× 836 0.9× 426 0.8× 433 1.4× 276 1.0× 44 2.7k
Sylvain Fleury Switzerland 20 1.5k 1.6× 1.0k 1.1× 486 0.9× 444 1.5× 555 2.1× 39 2.4k
Shawn P. O’Neil United States 23 1.2k 1.2× 1.3k 1.3× 455 0.9× 324 1.1× 529 2.0× 42 2.1k
T A Wiltrout United States 17 737 0.8× 710 0.7× 434 0.8× 338 1.1× 289 1.1× 20 1.5k
R A Yetter United States 20 1.2k 1.3× 665 0.7× 237 0.4× 354 1.2× 552 2.1× 33 2.1k
Maurizio Carbonari Italy 21 839 0.9× 501 0.5× 203 0.4× 378 1.2× 335 1.3× 52 1.6k
Christine Lacabaratz France 24 1.6k 1.6× 1.5k 1.6× 744 1.4× 488 1.6× 468 1.8× 53 2.6k
M A Gonda United States 12 416 0.4× 665 0.7× 345 0.7× 606 2.0× 307 1.2× 17 1.6k
Marcella Sarzotti United States 19 1.1k 1.2× 234 0.2× 245 0.5× 453 1.5× 401 1.5× 39 1.8k
Anna Smed‐Sörensen Sweden 26 1.7k 1.8× 562 0.6× 349 0.7× 386 1.3× 383 1.5× 60 2.3k

Countries citing papers authored by Luisa Marcon

Since Specialization
Citations

This map shows the geographic impact of Luisa Marcon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Marcon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Marcon more than expected).

Fields of papers citing papers by Luisa Marcon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Marcon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Marcon. The network helps show where Luisa Marcon may publish in the future.

Co-authorship network of co-authors of Luisa Marcon

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Marcon. A scholar is included among the top collaborators of Luisa Marcon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Marcon. Luisa Marcon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groot, Anne S. De, Luisa Marcon, Elizabeth Bishop, et al.. (2005). HIV vaccine development by computer assisted design: the GAIA vaccine. Vaccine. 23(17-18). 2136–2148. 71 indexed citations
2.
Groot, Anne S. De, Julie A. McMurry, Luisa Marcon, et al.. (2005). Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine. 23(17-18). 2121–2131. 79 indexed citations
3.
Aquaro, Stefano, Valentina Svicher, Francesca Ceccherini‐Silberstein, et al.. (2005). Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages. Journal of Antimicrobial Chemotherapy. 55(6). 872–878. 13 indexed citations
4.
Groot, Anne S. De, Elizabeth Bishop, Michelle Lally, et al.. (2004). Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. Methods. 34(4). 476–487. 40 indexed citations
5.
Ceccherini‐Silberstein, Francesca, Fulvio Erba, Federico Gago, et al.. (2004). Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure. AIDS. 18(12). 11–19. 60 indexed citations
6.
Perno, Carlo Federico, Alessandra Cenci, Roberta D’Arrigo, et al.. (2003). HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment. Scandinavian Journal of Infectious Diseases. 35(11). 37–40.
7.
Schenten, Dominik, Luisa Marcon, Gunilla B. Karlsson, et al.. (1999). Effects of Soluble CD4 on Simian Immunodeficiency Virus Infection of CD4-Positive and CD4-Negative Cells. Journal of Virology. 73(7). 5373–5380. 53 indexed citations
8.
Karlsson, Gunilla B., Matilda Halloran, Dominik Schenten, et al.. (1998). The Envelope Glycoprotein Ectodomains Determine the Efficiency of CD4+ T Lymphocyte Depletion in Simian– Human Immunodeficiency Virus–Infected Macaques. The Journal of Experimental Medicine. 188(6). 1159–1171. 90 indexed citations
9.
Marcon, Luisa & Joseph Sodroski. (1997). High Degree of Sensitivity of the Simian Immunodeficiency Virus (SIV mac ) Envelope Glycoprotein Subunit Association to Amino Acid Changes in the Glycoprotein 41 Ectodomain. AIDS Research and Human Retroviruses. 13(6). 441–447. 10 indexed citations
10.
Marcon, Luisa, Hyeryun Choe, Kathleen A. Martin, et al.. (1997). Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. Journal of Virology. 71(3). 2522–2527. 130 indexed citations
11.
Martin, Kathleen A., Richard T. Wyatt, Michael Farzan, et al.. (1997). CD4-Independent Binding of SIV gp120 to Rhesus CCR5. Science. 278(5342). 1470–1473. 95 indexed citations
12.
Farzan, Michael, Hyeryun Choe, Kathleen A. Martin, et al.. (1997). Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection. The Journal of Experimental Medicine. 186(3). 405–411. 246 indexed citations
13.
Marcon, Luisa, Frank H. Michaels, Naoko Hattori, et al.. (1991). Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication. Journal of Virology. 65(7). 3938–3942. 25 indexed citations
14.
Beaurain, Geneviève, Luisa Marcon, Gilles Grateau, et al.. (1989). In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney International. 36(4). 636–644. 79 indexed citations
15.
Lawrence, E. Clinton, et al.. (1988). Elevated Concentrations of Soluble Interleukin-2 Receptors in Serum Samples and Bronchoalveolar Lavage Fluids in Active Sarcoidosis. American Review of Respiratory Disease. 137(4). 759–764. 102 indexed citations
16.
Goldstein, Allan M., Luisa Marcon, Bryan R. Cullen, & David L. Nelson. (1988). A competitive Enzyme-Linked Immunoassay (ELISA) for the measurement of soluble human interleukin-2 receptors (IL-2R, Tac protein). Journal of Immunological Methods. 107(1). 103–109. 9 indexed citations
17.
Marcon, Luisa, et al.. (1988). Elevated Serum Levels of Soluble Tac Peptide in Adult T-Cell Leukemia: Correlation with Clinical Status during Chemotherapy. Annals of Internal Medicine. 109(4). 274–279. 54 indexed citations
18.
Marcon, Luisa, et al.. (1988). Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL).. PubMed. 73(1). 29–33. 49 indexed citations
19.
Steis, RG, et al.. (1988). Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood. 71(5). 1304–1309. 70 indexed citations
20.
Steis, RG, et al.. (1988). Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood. 71(5). 1304–1309. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory F. Burton Breakdown of academic impact, for papers by Sylvain Fleury Breakdown of academic impact, for papers by Shawn P. O’Neil Breakdown of academic impact, for papers by T A Wiltrout Breakdown of academic impact, for papers by R A Yetter Breakdown of academic impact, for papers by Maurizio Carbonari Breakdown of academic impact, for papers by Christine Lacabaratz Breakdown of academic impact, for papers by M A Gonda Breakdown of academic impact, for papers by Marcella Sarzotti Breakdown of academic impact, for papers by Anna Smed‐Sörensen
Rankless by CCL
2026